You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Chemokines and their receptors in the esophageal carcinoma tumor microenvironment: key factors for metastasis and progression
- 2. Scientists create a type of catalog, the 'colocatome,' of non-cancerous cells' influence on cancer
- 3. Walking, moving more may lower risk of cardiovascular death for women with cancer history
- 4. Revolutionising cancer treatment: targeting EZH2 for a new era of precision medicine
- 5. Mapping clinical and imaging factors that might predict cardiac events in breast cancer patients
- 6. Integrating quantitative DCE-MRI parameters and radiomic features for improved IDH mutation prediction in gliomas
- 7. Efficacy of thunder-fire moxibustion for cancer-related fatigue in breast cancer survivors: study protocol for a randomized controlled trial
- 8. EZH2: An analysis of a potential new tumor marker in high-risk localization of cutaneous squamous cell carcinomas
- 9. New avenues in breast cancer treatment: The role of ubiquitin-specific proteases in programmed cell death
- 10. Pfizer and Arvinas's HER2-breast cancer drug extends PFS in certain patients
Last updated at 23:06 GMT
Hot News Makers
Health/Pharma Companies
-
278682.56
-
77483.83
-
24029.09
-
16585.22
-
11167.06
-
7915.40
-
6908.42
-
6638.58
-
5934.21
-
5770.77
Drugs, Treatments, Trials
-
11416.26
-
9574.93
-
7452.90
-
5762.55
-
5748.34
-
4311.26
-
4037.59
-
4012.58
-
3991.59
-
3879.24
Last updated at 22:10 GMT
